ScopeUniversitätsklinikum Bonn Institut für Humangenetik
171 capabilities
Accredited since July 2025
Verified Apr 2026
One of 3,039 in Germany
Details
Venusberg-Campus 1
Bonn 53127 , Germany
Bonn 53127 , Germany
Accreditation
Active
DAkkS
D-ML-13125-03-01
Focuses on molecular human genetics and cytogenetics testing, offering PCR-based and next-generation sequencing methods with sequence capture and Sanger sequencing capabilities on blood, DNA, oral mucosa, and saliva samples.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13125-03-01
Status
ActiveSince
18 July 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFSend an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.
Test Capabilities (171)
| Standard Reference | Description | Category |
|---|---|---|
| Angeborener Chromosomensatz | angeborener Chromosomensatz | Biocompatibility (ISO 10993) |
| (gesamt) | IgE (gesamt) | Electrical |
| (Viruspanel) | (Viruspanel) | Food Safety Testing |
| (Chromosomen 13, 18, 21, X, Y) | (Chromosomen 13, 18, 21, X, Y) | Molecular Diagnostics / PCR |
| (GIST) | Stromatumore (GIST) | Molecular Diagnostics / PCR |
| (Illumina TruSight Cardio Panel): | (Illumina TruSight Cardio Panel): | Molecular Diagnostics / PCR |
| (Illumina TruSight EBM Panel): | (Illumina TruSight EBM Panel): | Molecular Diagnostics / PCR |
| (dbSNP rs3918290, rs55886062, rs67376798, rs75017182) | (dbSNP rs3918290, rs55886062, rs67376798, rs75017182) | Molecular Diagnostics / PCR |
| ABCC9, ACTA1, ACTN2, AKAP9, ANK2, BAG3, CACNA1C, CACNA2D1, CACNB2, CALM1,CASQ2, CAV3, CSRP3, DES, DSG2, DSP, DTNA, EMD, GLA, GPD1L, HCN4, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNJ8, KCNQ1, LAMP2, LDB3, LMNA, MYBPC3, MYH6, MYH7, MYL2, MYL3, NEXN, NKX2-5, PKP2, PLN, PRKAG2, RAF1, RANGRF, RBM20, RYR2, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SGCD, SNTA1, TAZ, TMEM43, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TRPM4, TTR, VCL | ABCC9, ACTA1, ACTN2, AKAP9, ANK2, BAG3, CACNA1C, CACNA2D1, CACNB2, CALM1,CASQ2, CAV3, CSRP3, DES, DSG2, DSP, DTNA, EMD, GLA, GPD1L, HCN4, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNJ8, KCNQ1, LAMP2, LDB3, LMNA, MYBPC3, MYH6, MYH7, MYL2, MYL3, NEXN, NKX2-5, PKP2, PLN, PRKAG2, RAF1, RANGRF, RBM20, RYR2, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SGCD, SNTA1, TAZ, TMEM43, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TRPM4, TTR, VCL | Molecular Diagnostics / PCR |
| ACD, BAP1, CDK4, CDKN2A, MITF, POT1, PTEN, TERT, TP53 | ACD, BAP1, CDK4, CDKN2A, MITF, POT1, PTEN, TERT, TP53 | Molecular Diagnostics / PCR |
| ACTA2, COL3A1, FBN1, MYH11, MYLK, SMAD3, TGFB2, TGFBR1, TGFBR2 | ACTA2, COL3A1, FBN1, MYH11, MYLK, SMAD3, TGFB2, TGFBR1, TGFBR2 | Molecular Diagnostics / PCR |
| APC, BMPR1A, BUB1B, MSH3, MUTYH, NTHL1, POLD1, POLE, PTEN, RPS20, SMAD4, STK11, TP53, AXIN2, GREM1, RNF43 | APC, BMPR1A, BUB1B, MSH3, MUTYH, NTHL1, POLD1, POLE, PTEN, RPS20, SMAD4, STK11, TP53, AXIN2, GREM1, RNF43 | Molecular Diagnostics / PCR |
| APC, BRCA2, PALB2, PTCH1, SUFU, TP53 | APC, BRCA2, PALB2, PTCH1, SUFU, TP53 | Molecular Diagnostics / PCR |
| APC, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE,PTCH1, SMARCE1, SUFU, TP53, NF1, NF2, TSC1, TSC2 | APC, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE,PTCH1, SMARCE1, SUFU, TP53, NF1, NF2, TSC1, TSC2 | Molecular Diagnostics / PCR |
| APC, DICER1, ESR2, PRKAR1A, PTEN, RET, SDHB, SDHC, SDHD, TP53 | APC, DICER1, ESR2, PRKAR1A, PTEN, RET, SDHB, SDHC, SDHD, TP53 | Molecular Diagnostics / PCR |
| ATM, BRCA1, BRCA2, CDKN2A, PALB2, STK11, TP53 | ATM, BRCA1, BRCA2, CDKN2A, PALB2, STK11, TP53 | Molecular Diagnostics / PCR |
| AZF (Männliche Infertilität) | AZF (Männliche Infertilität) | Molecular Diagnostics / PCR |
| Alzheimer-Demenz | Hereditäre Alzheimer Demenz: | Molecular Diagnostics / PCR |
| Aneuploidien | Aneuploidien | Molecular Diagnostics / PCR |
| BAP1, BHD/FLCN, FH, MET, PTEN, SDHB, SDHD, TP53, TSC1, TSC2, VHL, WT1 | BAP1, BHD/FLCN, FH, MET, PTEN, SDHB, SDHD, TP53, TSC1, TSC2, VHL, WT1 | Molecular Diagnostics / PCR |
| BAP1, CHEK2, EGFR, TP53 | BAP1, CHEK2, EGFR, TP53 | Molecular Diagnostics / PCR |
| BHD/FLCN | BHD/FLCN | Molecular Diagnostics / PCR |
| BRCA1 (HBOC) | BRCA1 (HBOC) | Molecular Diagnostics / PCR |
| BRCA1, BRCA2, ATM, CHEK2, PALB2, RAD51C, RAD51D, BRIP1, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE, RAD51D, STK11, TP53 | BRCA1, BRCA2, ATM, CHEK2, PALB2, RAD51C, RAD51D, BRIP1, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE, RAD51D, STK11, TP53 | Molecular Diagnostics / PCR |
| BRCA2, CHEK2 (HBOC) | BRCA2, CHEK2 (HBOC) | Molecular Diagnostics / PCR |
| Bannayan-Ruvalcaba-Riley-Syndrom | Bannayan-Ruvalcaba-Riley-Syndrom | Molecular Diagnostics / PCR |
| Birt-Hogg-Dubé-Syndrom | Birt-Hogg-Dubé-Syndrom | Molecular Diagnostics / PCR |
| Brustkrebs bei V. a. anderes | Brustkrebs bei V. a. anderes | Molecular Diagnostics / PCR |
| CDH1 | CDH1 | Molecular Diagnostics / PCR |
| CDH1, CTNNA1, EPCAM, MLH1, MSH2, MSH6, PMS2, SMAD4, STK11, TP53 | CDH1, CTNNA1, EPCAM, MLH1, MSH2, MSH6, PMS2, SMAD4, STK11, TP53 | Molecular Diagnostics / PCR |
| CDKN1B, MEN1 | CDKN1B, MEN1 | Molecular Diagnostics / PCR |
| CDKN2A, CDK4 | CDKN2A, CDK4 | Molecular Diagnostics / PCR |
| CFTR (Mukoviszidose, CBAVD) | CFTR (Mukoviszidose, CBAVD) | Molecular Diagnostics / PCR |
| COL3A1 (Ehlers-Danlos-Syndrom) | COL3A1 (Ehlers-Danlos-Syndrom) | Molecular Diagnostics / PCR |
| Dermatologische Erkrankungen, gesamt: ADAM10, APCDD1, CDH3, | Dermatologische Erkrankungen, gesamt: ADAM10, APCDD1, CDH3, | Molecular Diagnostics / PCR |
| Dihydro-Pyrimidin-Dehydrogenase- | Dihydropyrimidin-Dehydrogenase | Molecular Diagnostics / PCR |
| EPCAM, MLH1, MSH2, MSH6, MUTYH, NTHL1, PMS2, POLD1, POLE, PTEN, TP53 | EPCAM, MLH1, MSH2, MSH6, MUTYH, NTHL1, PMS2, POLD1, POLE, PTEN, TP53 | Molecular Diagnostics / PCR |
| EXT1, EXT2 | EXT1, EXT2 | Molecular Diagnostics / PCR |
| EXT1, EXT2 (Multiple Exostosis) | EXT1, EXT2 (Multiple Exostosis) | Molecular Diagnostics / PCR |
| Eiigkeitsbestimmung | Eiigkeitsbestimmung | Molecular Diagnostics / PCR |
| Erblicher Darmkrebs | Erblicher Darmkrebs | Molecular Diagnostics / PCR |
| Erweiterung des Illumina TruSight | Erweiterung des Illumina TruSight | Molecular Diagnostics / PCR |
| FBN1 (Marfan-Syndrom) | FBN1 (Marfan-Syndrom) | Molecular Diagnostics / PCR |
| FH (Hereditärer Nierenkrebs) | FH (Hereditärer Nierenkrebs) | Molecular Diagnostics / PCR |
| Fragiles-X-Syndrom, POF, FXTAS: | Fragiles-X-Syndrom, POF, FXTAS: | Molecular Diagnostics / PCR |
| GJB1, MPZ, PMP22 (CMT1/HMSN) | GJB1, MPZ, PMP22 (CMT1/HMSN) | Molecular Diagnostics / PCR |
| GRHL3 | GRHL3 | Molecular Diagnostics / PCR |
| HNF1A (TCF1) | HNF1A (TCF1) | Molecular Diagnostics / PCR |
| HNPCC/Lynch-Syndrom | HNPCC/Lynch-Syndrom | Molecular Diagnostics / PCR |
| HOXB13 (Mut. G84E) | HOXB13 (Mut. G84E) | Molecular Diagnostics / PCR |
| Hereditäre Frontotemporale | Hereditäre Frontotemporale | Molecular Diagnostics / PCR |
| Hereditäre Gastrointestinale | Hereditäre Gastrointestinale | Molecular Diagnostics / PCR |
| Hereditäre Leiomyomatose und | Hereditäre Leiomyomatose und | Molecular Diagnostics / PCR |
| Hereditäre Multiple Endokrine | Hereditäre Multiple Endokrine | Molecular Diagnostics / PCR |
| Hereditäre Neurofibromatose Typ | Hereditäre Neurofibromatose Typ | Molecular Diagnostics / PCR |
| Hereditäre Schwannomatose | Hereditäre Schwannomatose | Molecular Diagnostics / PCR |
| Hereditäre Tuberöse Sklerose Typ | Hereditäre Tuberöse Sklerose Typ | Molecular Diagnostics / PCR |
| Hereditäre Zylindromatosis | Hereditäre Zylindromatosis | Molecular Diagnostics / PCR |
| Hereditärer Brust- und | Hereditärer Brust- und | Molecular Diagnostics / PCR |
| Hereditärer Hirntumor | Hereditärer Hirntumor | Molecular Diagnostics / PCR |
| Hereditärer Magenkrebs | Hereditärer Magenkrebs | Molecular Diagnostics / PCR |
| Hereditärer Nierenkrebs | Hereditärer Nierenkrebs | Molecular Diagnostics / PCR |
| Hereditärer Schilddrüsenkrebs | Hereditärer Schilddrüsenkrebs | Molecular Diagnostics / PCR |
| Hereditärer Wilms-Tumor | Hereditärer Wilms-Tumor | Molecular Diagnostics / PCR |
| Hereditäres Angioödem Typ I-III | Hereditäres Angioödem Typ I-III | Molecular Diagnostics / PCR |
| Hereditäres Endometriumkarzinom | Hereditäres Endometriumkarzinom | Molecular Diagnostics / PCR |
| Hereditäres Hepatisches Adenom | Hereditäres Hepatisches Adenom | Molecular Diagnostics / PCR |
| Hereditäres Lungenkarzinom | Hereditäres Lungenkarzinom | Molecular Diagnostics / PCR |
| Hereditäres Medulloblastom | Hereditäres Medulloblastom | Molecular Diagnostics / PCR |
| Hereditäres Melanom | Hereditäres Melanom | Molecular Diagnostics / PCR |
| Hereditäres Ovarialkarzinom | Hereditäres Ovarialkarzinom | Molecular Diagnostics / PCR |
| Hereditäres Pankreaskarzinom | Hereditäres Pankreaskarzinom | Molecular Diagnostics / PCR |
| Hereditäres Phäochromozytom | Hereditäres Phäochromozytom | Molecular Diagnostics / PCR |
| Hereditäres Pleuropulmonales | Hereditäres Pleuropulmonales | Molecular Diagnostics / PCR |
| Hereditäres Prostatakarzinom | Hereditäres Prostatakarzinom | Molecular Diagnostics / PCR |
| Herzerkrankungen, gesamt | Herzerkrankungen, gesamt | Molecular Diagnostics / PCR |
| IRF6 | IRF6 | Molecular Diagnostics / PCR |
| Kontaminationsausschluss/ | Kontaminationsausschluss/ | Molecular Diagnostics / PCR |
| LZTR1, NF2, SMARCB1 | LZTR1, NF2, SMARCB1 | Molecular Diagnostics / PCR |
| Li Fraumeni Syndrom | Li-Fraumeni-Syndrom | Molecular Diagnostics / PCR |
| MECP2 (Rett-Syndrom) | MECP2 (Rett-Syndrom) | Molecular Diagnostics / PCR |
| MLH1, MSH2 (HNPCC, CMMRD) | MLH1, MSH2 (HNPCC, CMMRD) | Molecular Diagnostics / PCR |
| MLH1, MSH2, MSH6, PMS2, EPCAM | MLH1, MSH2, MSH6, PMS2, EPCAM | Molecular Diagnostics / PCR |
| MSH6 (HNPCC, CMMRD) | MSH6 (HNPCC, CMMRD) | Molecular Diagnostics / PCR |
| MeCP2; Rett-Syndrom | MeCP2; Rett-Syndrom | Molecular Diagnostics / PCR |
| NF1 | NF1 | Molecular Diagnostics / PCR |
| NF1, SPRED1 | NF1, SPRED1 | Molecular Diagnostics / PCR |
| NF2 | NF2 | Molecular Diagnostics / PCR |
| NSD1, NFIX (Sotos-Syndrom) | NSD1, NFIX (Sotos-Syndrom) | Molecular Diagnostics / PCR |
| PDGFRA, SDHA, SDHB, SDHC, SDHD | PDGFRA, SDHA, SDHB, SDHC, SDHD | Molecular Diagnostics / PCR |
| PMS2 (HNPCC, CMMRD) | PMS2 (HNPCC, CMMRD) | Molecular Diagnostics / PCR |
| PSEN1, PSEN2 | PSEN1, PSEN2 | Molecular Diagnostics / PCR |
| PTCH1 (Gorlin-Syndrom) | PTCH1 (Gorlin-Syndrom) | Molecular Diagnostics / PCR |
| PTEN, AKT1, PIK3CA, SEC23B | PTEN, AKT1, PIK3CA, SEC23B | Molecular Diagnostics / PCR |
| Peutz-Jeghers Syndrom | STK11; V. a. Peutz-Jeghers-Syndrom | Molecular Diagnostics / PCR |
| Popliteales Pterygium-Syndrom: | Popliteales Pterygium-Syndrom: | Molecular Diagnostics / PCR |
| RET (MEN2) | RET (MEN2) | Molecular Diagnostics / PCR |
| RHBDF2 | RHBDF2 | Molecular Diagnostics / PCR |
| Rhabdoid-Prädispositions-Syndrom | Rhabdoid-Prädispositions-Syndrom | Molecular Diagnostics / PCR |
| SDHAF2 | SDHAF2 | Molecular Diagnostics / PCR |
| SHOX (Kleinwuchssyndrom) | SHOX (Kleinwuchssyndrom) | Molecular Diagnostics / PCR |
| SMARCB1, SMARCA4 | SMARCB1, SMARCA4 | Molecular Diagnostics / PCR |
| SPRED1 (Hereditäre NF1) | SPRED1 (Hereditäre NF1) | Molecular Diagnostics / PCR |
| STK11, PRKAR1A | STK11, PRKAR1A | Molecular Diagnostics / PCR |
| Syndrom-Screening, MR-X | Syndrom-Screening, MR-X | Molecular Diagnostics / PCR |
| TBX1 (DiGeorge Syndrom) | TBX1 (DiGeorge Syndrom) | Molecular Diagnostics / PCR |
| TGFBR1, TGFBR2 (Marfan-Syndrom) | TGFBR1, TGFBR2 (Marfan-Syndrom) | Molecular Diagnostics / PCR |
| TP53 (Li-Fraumeni-Syndrom) | TP53 (Li-Fraumeni-Syndrom) | Molecular Diagnostics / PCR |
| TP53, CHEK2, POT1 | TP53, CHEK2, POT1 | Molecular Diagnostics / PCR |
| TSC1 (Tuberöse Sklerose Typ 1) | TSC1 (Tuberöse Sklerose Typ 1) | Molecular Diagnostics / PCR |
| TSC2 (Tuberöse Sklerose Typ 2) | TSC2 (Tuberöse Sklerose Typ 2) | Molecular Diagnostics / PCR |
| Testung (DPD)/5-FU-Toxizität: DPYD | Testung (DPD)/5-FU-Toxizität: DPYD | Molecular Diagnostics / PCR |
| Thorakale Aortenerweiterung | Thorakale Aortenerweiterung | Molecular Diagnostics / PCR |
| VHL (Von-Hippel-Lindau-Syndrom) | VHL (Von-Hippel-Lindau-Syndrom) | Molecular Diagnostics / PCR |
| Van der Woude-Syndrom | Van der Woude-Syndrom | Molecular Diagnostics / PCR |
| WT1 (Wilms-Tumor) | WT1 (Wilms-Tumor) | Molecular Diagnostics / PCR |
| XII (Hagemann-Faktor) F12, PLG, ANGPT1 | XII (Hagemann-Faktor) F12, PLG, ANGPT1 | Molecular Diagnostics / PCR |
| Ösophaguskarzinom | Ösophaguskarzinom | Molecular Diagnostics / PCR |
| (institutseigene Erweiterung des | (institutseigene Erweiterung des | Other |
| 1/2 (institutseigene Erweiterung | 1/2 (institutseigene Erweiterung | Other |
| AIP | AIP | Other |
| APC | APC | Other |
| APP, PSEN1, PSEN2 (Hereditäre | APP, PSEN1, PSEN2 (Hereditäre | Other |
| ATM | ATM | Other |
| Alzheimer Demenz) | Alzheimer Demenz) | Other |
| Angioödem) | Angioödem) | Other |
| BMPR1, SMAD4, PTEN (Juvenile | BMPR1, SMAD4, PTEN (Juvenile | Other |
| Blastom (institutseigene | Blastom (institutseigene | Other |
| CBAVD (Illumina TruSight EBM | CBAVD (Illumina TruSight EBM | Other |
| CLOVES-Syndrom (institutseigene | CLOVES-Syndrom (institutseigene | Other |
| CYLD | CYLD | Other |
| Cancer Panel): ACVRL1, ENG, SMAD4 | Illumina TruSight Cancer Panel): | Other |
| Carney-Komplex (institutseigene | Carney-Komplex (institutseigene | Other |
| Carney-Komplex) | Carney-Komplex) | Other |
| Cowden-Syndrom (institutseigene | Cowden-Syndrom (institutseigene | Other |
| DMD (Muskeldystrophie Typ | DMD (Muskeldystrophie Typ | Other |
| Demenz | Demenz | Other |
| Duchenne/Becker) | Duchenne/Becker) | Other |
| EBM Panel): FBN1, TGFBR1, TGFBR2 | EBM Panel): FBN1, TGFBR1, TGFBR2 | Other |
| ELN, LIMK1 (Williams Beuren | ELN, LIMK1 (Williams Beuren | Other |
| Ehlers-Danlos-Syndrom (Illumina | Ehlers-Danlos-Syndrom (Illumina | Other |
| Eierstockkrebs (institutseigene | Eierstockkrebs (institutseigene | Other |
| FMR1 | Tremor-Ataxie-Syndrom (FMR1 | Other |
| Frontotemporale Demenz) | Frontotemporale Demenz) | Other |
| Hereditäre Tylosis (Keratosis | Hereditäre Tylosis (Keratosis | Other |
| Hereditäres | SERPING1, F12 (Hereditäres | Other |
| MAPT, GRN (Hereditäre | MAPT, GRN (Hereditäre | Other |
| Marfan-Syndrom (Illumina TruSight | Marfan-Syndrom (Illumina TruSight | Other |
| Morbus Osler (institutseigene | Morbus Osler (institutseigene | Other |
| Neoplasie, Typ 1/4 (institutseigene | Neoplasie, Typ 1/4 (institutseigene | Other |
| Neoplasie, Typ 2 (institutseigene | Neoplasie, Typ 2 (institutseigene | Other |
| Nierenzellkarzinom (institutseigene | Nierenzellkarzinom (institutseigene | Other |
| Paragangliom (institutseigene | Paragangliom (institutseigene | Other |
| Polyposis) | Polyposis) | Other |
| Proteus-Syndrom (institutseigene | Proteus-Syndrom (institutseigene | Other |
| SMARCB1 (Hereditäre | SMARCB1 (Hereditäre | Other |
| SUFU | SUFU | Other |
| Schwannomatose) | Schwannomatose) | Other |
| Syndrom (CMMRD) (institutseigene | Syndrom (CMMRD) (institutseigene | Other |
| Syndrom (institutseigene | Syndrom (institutseigene | Other |
| Syndrom) | Syndrom) | Other |
| TruSight EBM Panel): COL3A1, COL5A1, COL5A2 | TruSight EBM Panel): COL3A1, COL5A1, COL5A2 | Other |
| Tumorsyndrom (institutseigene | Tumorsyndrom (institutseigene | Other |
| Typ1+2 (institutseigene Erweiterung | Typ1+2 (institutseigene Erweiterung | Other |
| VHL | VHL | Other |
| gastrointestinal (institutseigene | gastrointestinal (institutseigene | Other |
| hereditär (institutseigene | hereditär (institutseigene | Other |
| isoliert (institutseigene Erweiterung | isoliert (institutseigene Erweiterung | Other |
| medullär (institutseigene | medullär (institutseigene | Other |
| palmoplantaris) mit | palmoplantaris) mit | Other |
| papilläres (institutseigene | papilläres (institutseigene | Other |